Industry
Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing
Irish specialty pharmaceutical company Xeolas Pharmaceuticals officially opens a new 158,000 square foot state-of-the-art facility in Baldoyle, Dublin. The site unifies research, development, formulation, clinical supply, and commercial manufacturing for over 25 pipeline products across 21 countries.

Industry
Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich
Priya Life Science joins as an official Media Partner for Fleming Events' 9th Annual Corporate Compliance & Transparency in Life Sciences Summit, taking place November 17-18, 2026 in Zurich, Switzerland. Includes an exclusive 20% registration discount code (corporate20) for our readers.

Industry
AI Will Not Rescue Ireland's Over-Budget Health IT Projects. Pharma-Grade Governance Might.
Ireland is entering a 1.5 to 2 billion euro National Electronic Health Record programme with a poor record on large health IT projects. PPARS and the 2021 cyberattack were governance failures, not technology failures, and AI project tools inherit the optimism they are fed. This analysis argues that the discipline the HSE needs already exists in Irish pharma and MedTech under GAMP 5 and the FDA's Computer Software Assurance guidance.

Industry
Jazz Pharmaceuticals Prices Upsized 1.1 Billion Dollar Exchangeable Senior Notes Offering
Jazz Pharmaceuticals has priced an upsized private offering of $1.1 billion in 1.875% exchangeable senior notes due 2032, paired with a concurrent $225 million ordinary share repurchase.

Industry
AI Governance Is Becoming the Next Major Compliance Test for Life Sciences: Why Irish Leaders Must Benchmark in Zurich
As the EU AI Act, updated EFPIA codes, and multi-jurisdictional enforcement reshape life sciences, the 9th Annual Corporate Compliance & Transparency in Life Sciences Conference in Zurich sets the critical 2027 benchmark for Irish biopharma leaders.

Industry
Leveraging Real-Time Data Trackers for Clinical Trials and Regulatory Intelligence in the Life Sciences
A comprehensive guide to the architecture, databases, and clinical utility of the real-time data trackers on Priya Life Science, covering trial registries, HPRA authorizations, and supply chain monitors.

Industry
China Chunlai Education Secures HKEX Waiver for Dublin Business School Acquisition
China Chunlai Education has secured a waiver from the Hong Kong Stock Exchange extending the deadline for its circular regarding the $127.5 million acquisition of Dublin Business School.

Industry
Boston Scientific Prepares to Repatriate 15 Billion Dollars in Dividends from Irish Operation
Boston Scientific has completed a balance sheet reorganisation in Ireland, paving the way to distribute 15 billion dollars in dividends from its Irish subsidiary to global parents.

Industry
22 Irish Companies Recognized in Deloitte EMEA Technology Fast 500 List
Twenty-two high-growth technology companies from the island of Ireland have secured spots on the prestigious Deloitte EMEA Technology Fast 500 list, led by StormHarvester at 24th place.

Industry
SK Biopharmaceuticals Acquires Epilepsy Candidate Opakalim in 795 Million Dollar Deal
SK Biopharmaceuticals has secured the global licensing rights to Biohaven's selective Kv7 channel activator opakalim (BHV-7000) in a deal valued at up to $795 million.

Industry
Irish Venture Capital Association Urges Government to Unlock 1 Billion Euros in Pension Funds for Startups
The Irish Venture Capital and Private Equity Association (IVCA) has called for a strategic state-backed investment vehicle to channel domestic pension and institutional assets into local tech startups.

Industry
Ireland Reconsiders Nuclear Energy Ban as Data Center Power Demand Surges
Amid surging electricity consumption from data centers, which now account for 23% of Ireland's grid usage, the Irish government is debating the repeal of its 1999 nuclear power ban.
